Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(2.08) per share. This is a 48 percent increase over losses of $(4.00) per share from the same period last year.
RBC Capital Maintains Sector Perform on ECN Capital, Lowers Price Target to C$4
RBC Capital analyst Geoffrey Kwan maintains ECN Capital (TSX:ECN) with a Sector Perform and lowers the price target from C$5 to C$4.